Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Income from Continuing Operations (2019 - 2025)

Bioadaptives' Income from Continuing Operations history spans 7 years, with the latest figure at 823346.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 823346.0 for Q4 2025, down 121.46% from a year ago — trailing twelve months through Dec 2025 was 1619557.0 (down 148.01% YoY), and the annual figure for FY2025 was 1557898.0, down 73.26%.
  • Income from Continuing Operations for Q4 2025 was 823346.0 at Bioadaptives, down from 379502.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 19095.0 in Q4 2023 to a low of 823346.0 in Q4 2025.
  • The 5-year median for Income from Continuing Operations is 177084.0 (2022), against an average of 223249.4.
  • The sharpest move saw Income from Continuing Operations surged 106.86% in 2023, then plummeted 2047.04% in 2024.
  • Year by year, Income from Continuing Operations stood at 89602.0 in 2021, then plummeted by 210.84% to 278520.0 in 2022, then surged by 106.86% to 19095.0 in 2023, then plummeted by 2047.04% to 371788.0 in 2024, then plummeted by 121.46% to 823346.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 823346.0, 379502.0, and 157914.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.